Member Info for banker2

Bought some today

About time heading back to sensible level

Holding rns ...new buyer

27.2 percent that's nearly third of the company...
Think ill buy more now...follow the money

Might be buying more

5 million buy some one is knows something

Couple off late big buy trades showing as sells has just popped up...

Great news

Well its failed to go lower than recent low and now its turn to check recent high

Added more today ...think it's just taking the weak out

Are the derampers

Bought some...
128.4

·    Revenue up 28% to US$787 million due to higher iron ore fines prices and an increase in sales volumes

·    Underlying EBITDA up 59% to US$372 million (1H 2018: US$234 million)

·    Profit after tax up 78% to US$270 million

·    Declared interim ordinary dividend up 100% to 6.6 US cents (1H 2018: 3.3 US cents)

·    Net debt reduced to US$282 million (31 December 2018: US$339 million)

·    Capital investment doubled to US$114 million

 

Bought some

The current borrowing of £200m relates to the Class A3 notes for which the expected maturity date is 31 July 2020. This repayment of borrowings can be fully funded by a committed forward starting senior facility of £200m, which was undrawn at 31 July 2019 and has a maturity date of 31 July 2023.

 

The current borrowing of £200m relates to the Class A3 notes for which the expected maturity date is 31 July 2020. This repayment of borrowings can be fully funded by a committed forward starting senior facility of £200m, which was undrawn at 31 July 2019 and has a maturity date of 31 July 20

During the prior period, the Group repaid £300m of Class A3 notes. As a result, the Group incurred an early repayment penalty of £15m.

Normally it's a good time to buy when shorter start posting

Added some more today

News due....
Product progress

Duaklir® was initially approved in the European Union in 2014 and is approved in approximately 50 countries around the world under a number of brand names. In 2017 it completed a phase III clinical study designed to support a regulatory filing in the United States, which was submitted in Q2 2018. The product was subsequently approved in the US in March 2019 and launch is planned for H2 2019.